A version of this digest first appeared in the weekly STAT Health Tech newsletter. To receive future editions, sign up here.
Let’s start with a briefing on rapid financial maneuvering right now in the telehealth industry, and the significant risks that underlie it.
To catch you up: The nation’s largest telehealth companies are making big bets on a surge in demand amid the Covid-19 pandemic. Teladoc, the largest provider, is acquiring the online chronic disease company Livongo in an $18.5 billion deal, and Amwell, MDLive, and GoodRx — which operates a telehealth business called HeyDoctor — are all preparing for initial public offerings. The paperwork for those IPOs offer a new window into the long-murky picture of finances in telemedicine, as Rebecca explains in a new story that digs into the filings.